We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $7.73B
1-Year Est. Return 14.94%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+14.94%
3 Year Est. Return
+71.58%
5 Year Est. Return
+102.98%
10 Year Est. Return
+355.22%
AUM
$7.73B
AUM Growth
-$519M
Cap. Flow
-$140M
Cap. Flow %
-1.8%
Top 10 Hldgs %
36.71%
Holding
383
New
9
Increased
73
Reduced
191
Closed
15

Top Buys

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$11.1M
2
NFLX icon
Netflix
NFLX
+$10.1M
3
NOW icon
ServiceNow
NOW
+$6.9M
4
AVGO icon
Broadcom
AVGO
+$3.9M
5
CSL icon
Carlisle Companies
CSL
+$3.25M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$44.2M
2
ADBE icon
Adobe
ADBE
+$17.5M
3
BSX icon
Boston Scientific
BSX
+$10.7M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.16M
5
AAPL icon
Apple
AAPL
+$5.8M

Sector Composition

Rank Sector Weight
1 Technology 23.87%
2 Healthcare 16.45%
3 Financials 11.78%
4 Consumer Discretionary 10.95%
5 Industrials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
226
Morgan Stanley
MS
$337B
$931K 0.01%
5,657
-99
-2% -$17.1K
TFC icon
227
Truist Financial
TFC
$63.2B
$919K 0.01%
19,990
-518
-3% -$25.6K
CSX icon
228
CSX Corp
CSX
$98.6B
$911K 0.01%
22,185
-1,174
-5% -$46K
COF icon
229
Capital One
COF
$124B
$902K 0.01%
4,942
-537
-10% -$112K
WCN
230
Waste Connections
WCN
$42.8B
$902K 0.01%
5,550
BSM icon
231
Black Stone Minerals
BSM
$3.11B
$892K 0.01%
58,966
BIV icon
232
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$863K 0.01%
11,187
+254
+2% +$19.8K
IVW icon
233
iShares S&P 500 Growth ETF
IVW
$72.5B
$858K 0.01%
7,589
-178
-2% -$21.4K
WST icon
234
West Pharmaceutical
WST
$23.1B
$855K 0.01%
3,413
+552
+19% +$137K
IJK icon
235
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$842K 0.01%
8,373
VTI icon
236
Vanguard Total Stock Market ETF
VTI
$654B
$835K 0.01%
2,603
+139
+6% +$46.6K
MDLZ icon
237
Mondelez International
MDLZ
$77.7B
$830K 0.01%
14,399
-404
-3% -$23.4K
BND icon
238
Vanguard Total Bond Market
BND
$157B
$792K 0.01%
10,756
-2,113
-16% -$157K
NVO
239
Novo Nordisk
NVO
$216B
$783K 0.01%
21,297
-215
-1% -$10.2K
FORM icon
240
FormFactor
FORM
$8.11B
$776K 0.01%
8,000
TRV icon
241
Travelers Companies
TRV
$80.8B
$762K 0.01%
2,611
UL icon
242
Unilever
UL
$131B
$756K 0.01%
13,274
-138
-1% -$9.25K
GEHC icon
243
GE HealthCare
GEHC
$27.6B
$746K 0.01%
10,486
+126
+1% +$9.94K
VLTO icon
244
Veralto
VLTO
$22.6B
$741K 0.01%
8,378
-5,358
-39% -$509K
NEM icon
245
Newmont
NEM
$99.5B
$735K 0.01%
6,790
HSY icon
246
Hershey
HSY
$35.4B
$728K 0.01%
3,500
SHEL icon
247
Shell
SHEL
$245B
$721K 0.01%
7,753
-83
-1% -$6.71K
BRK.A icon
248
Berkshire Hathaway Class A
BRK.A
$1.07T
$718K 0.01%
1
IWN icon
249
iShares Russell 2000 Value ETF
IWN
$14.4B
$697K 0.01%
3,675
PHYS icon
250
Sprott Physical Gold
PHYS
$14.6B
$693K 0.01%
19,550

Similar funds

Welch & Forbes's Q1 2026 Portfolio in Review

As of Q1 2026, Welch & Forbes held 383 positions worth $7.73B, down 6.3% from $8.25B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Welch & Forbes's Q1 2026 filing shows 9 new, 73 increased, 191 reduced and 15 closed positions. Its largest new stake was Enterprise Products Partners: 29,295 shares worth $1.11M. The largest sale was NVIDIA, an estimated $44.2M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Welch & Forbes's largest Q1 2026 buy was Enterprise Products Partners: 29,295 shares worth $1.11M.
  • Welch & Forbes added most to Palo Alto Networks in Q1 2026, an estimated $11.1M increase.
  • Welch & Forbes's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $44.2M.
  • Welch & Forbes fully exited Boston Scientific in Q1 2026, selling an estimated $10.7M.
  • Welch & Forbes's ten largest holdings make up 37% of its $7.73B portfolio in Q1 2026.
  • Welch & Forbes opened 9 new positions and closed 15 in Q1 2026.
  • Welch & Forbes's portfolio value fell 6.3% quarter-over-quarter to $7.73B.

Based on Welch & Forbes's 13F filing for Q1 2026, filed 1 May 2026.